The U.S. Food and Drug Administration (FDA) has approved Filkri (filgrastim-laha), a biosimilar to Neupogen (filgrastim), to ...

Like all new parents, Arthur Zey and Chase Popp think their son Dax is the most perfect baby in the world. But they don't attribute their son's temperament to their paternal instincts alone.

Three University High students have started the Caring Cells Project to raise awareness and provide care packages for ...

J. Snow and Marlon Wayans Q&A for doc on sickle cell "You Look Fine" ...

Pain related to sickle cell disease (SCD) increases during menstruation, as do emergency department (ED) visits and hospitalizations, for many women and girls—according to a new, nationwide study led ...

Recent therapies like hydroxyurea (Droxia, Bristol-Myers Squibb), the first FDA-approved drug for SCD in 1994, increase fetal hemoglobin (HbF), which, through unknown pathways, improves SCD symptoms ...

Sickle cell anemia (HbSS) is the homozygous dominant variant and the most common and severe form of the disease. Whereas patients who only inherited one gene encoding for abnormal HbS and a different ...

A new breakthrough study led by researchers at the University of Minnesota Twin Cities could explain why patients with the ...

Black History Month is poignant for one family after a man got a historic, innovative treatment at Children's Hospital of Philadelphia.

A Black female doctor when that was rare, she developed a diagnostic test for the disease that is still a standard tool, as well as treatment guidelines. By Sam Roberts Dr. Angella D. Ferguson, a ...

Vertex Pharmaceuticals and bluebird bio have entered into an agreement with CMS to participate in a new Medicaid payment model for gene-based sickle cell anemia treatments, the agency announced ...

A new breakthrough study led by researchers at the University of Minnesota Twin Cities could explain why patients with the same genetic sickle cell mutation experience different levels of pain, organ ...